Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior cycle 1, day 1
Uncontrolled hypertension or diabetes
Have uncontrolled diabetes or have hypertension requiring more than 3 medications for control of hypertension.
Uncontrolled hypertension or diabetes
Uncontrolled diabetes or hypertension
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to start of treatment
Uncontrolled diabetes or hypertension
Uncontrolled hypertension, uncontrolled pulmonary hypertension or uncontrolled diabetes within 14 days prior to enrollment
Uncontrolled diabetes, hypertension or other medical conditions that may interfere with assessment of toxicity
Uncontrolled hypertension or uncontrolled diabetes
Must not have any uncontrolled hypertension or uncontrolled diabetes within 14 days prior to enrollment.
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to randomization
Patients who exhibit uncontrolled hypertension (>= 140/90 mmHg) or uncontrolled diabetes within 14 days prior to registration are NOT eligible for participation
Uncontrolled diabetes, heart disease, hypertension
Uncontrolled hypertension or diabetes.
Uncontrolled diabetes or uncontrolled hypertension within 14 days prior to first dose
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes despite medication
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to the first day of treatment
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to randomization
No uncontrolled hypertension or uncontrolled diabetes (as determined by the treating physician) within 14 days prior to cycle 1 day 1
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or diabetes.
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to signing consent
Patients must not have uncontrolled diabetes, uncontrolled infection despite antibiotics or uncontrolled hypertension within 30 days prior to registration
Uncontrolled hypertension or diabetes
Uncontrolled diabetes, hypertension or other medical conditions at the time of transition to this study that may interfere with assessment of toxicity
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or diabetes
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to randomization
Uncontrolled hypertension or uncontrolled diabetes within 14 days prior to randomization
Predisposing factors to retinal vein occlusion including uncontrolled hypertension, uncontrolled diabetes, uncontrolled hyperlipidemia, and coagulopathy.
Uncontrolled diabetes, hypertension or other medical conditions that may interfere with assessment of toxicity.
Have uncontrolled diabetes or have hypertension requiring more than 3 medications for control of hypertension.
Major co-morbidities (e.g., uncontrolled diabetes, hypertension, etc.)
History of chronic disease including diabetes, uncontrolled hypertension or thyroid disease
Subjects who have diabetes or uncontrolled hypertension are not eligible; NOTE: for the purposes of this study, uncontrolled will be defined as diastolic pressure over 100 mmHg
Uncontrolled chronic illness such as hypertension, diabetes, or heart failure
Predisposing factors to retinal vein occlusion, including uncontrolled hypertension, uncontrolled diabetes, uncontrolled hyperlipidemia, and coagulopathy
